Cargando…
Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679671/ https://www.ncbi.nlm.nih.gov/pubmed/29138565 http://dx.doi.org/10.2147/IJN.S153053 |
Ejemplares similares
-
Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control
por: Shen, Yao An, et al.
Publicado: (2015) -
Corrigendum to “Sustained-Release Fillers for Dentin Disinfection: An Ex Vivo Study”
por: Funk, Bernhard, et al.
Publicado: (2022) -
Antitumor Activity of Larotrectinib in Tumors Harboring NTRK Gene Fusions: A Short Review on the Current Evidence [Corrigendum]
Publicado: (2020) -
A High Bioavailability and Sustained-Release Nano-Delivery System for Nintedanib Based on Electrospray Technology [Corrigendum]
Publicado: (2021) -
EPR Effect-Based Tumor Targeted Nanomedicine: A Promising Approach for Controlling Cancer
por: Fang, Jun
Publicado: (2022)